Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[11C]PF-06809247 Binding Kinetics in Healthy Males
NCT03100136Phase 1Completed
- Sponsor
- Pfizer
- Start
- Nov 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of PF-06809247 in neuroinflammation, sponsored by Pfizer. Primary endpoint: Binding kinetics of the novel tracer. Started Nov 2016; status: completed.
02
Drugs
PF-06809247
03
Conditions
neuroinflammation
Beyond the preview
Go deeper on NCT03100136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03100136.